Dimethyl fumarate, a two‐edged drug: current status and future directions

NEB Saidu, N Kavian, K Leroy, C Jacob… - Medicinal research …, 2019 - Wiley Online Library
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing‐
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …
被引用次数：121 相关文章
[PDF] researchgate.net

[PDF][PDF] Dimethyl fumarate, a two‐edged drug: Current status and future directions

NEB Saidu, N Kavian, K Leroy, C Jacob, C Nicco… - researchgate.net
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing‐
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …

Dimethyl fumarate, a two-edged drug: Current status and future directions.

NEB Saidu, N Kavian, K Leroy, C Jacob… - Medicinal Research …, 2019 - europepmc.org
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing-
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …

Dimethyl fumarate, a two-edged drug: Current status and future directions

NEB Saidu, NC Kavian-Tessler, K Leroy… - Medicinal Research …, 2019 - hub.hku.hk
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing-
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …

Dimethyl fumarate, a two‐edged drug: Current status and future directions

NEB Saidu, N Kavian, K Leroy, C Jacob… - Medicinal Research …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Dimethyl fumarate (DMF) is a fumaric acid
ester registered for the treatment of relapsing‐remitting multiple sclerosis (RRMS). It induces …

Dimethyl fumarate, a two‐edged drug: Current status and future directions.

NEB Saidu, N Kavian, K Leroy… - Medicinal Research …, 2019 - search.ebscohost.com
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing‐
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …

Dimethyl fumarate, a two-edged drug: Current status and future directions

NEB Saidu, N Kavian, K Leroy… - Medicinal research …, 2019 - pubmed.ncbi.nlm.nih.gov
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing-
remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of …